EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Skin autofluorescence may be a biomarker associated suboptimal glycemic control in pregnant women with gestational diabetes mellitus

Manel Salsabil Alakrab, Dhekra Toumi, Ameni Selmi, Ahmed Hajji, Olfa Zoukar, Salwa Abid, Raja Faleh, Mohsen Kerkeni iD

Diabetes & Vascular Disease Research · 2026-07 · 23 (4)

DOI: 10.1177/14791641251398558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Vascular Disease Research, online erschienen am 28.07.2026. Verfasst von Manel Salsabil Alakrab und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Research on Biologically Compatible Compounds, Faculty of Dental Medicine, University of Monastir, Monastir, Tunisia. Hauptthemen laut MEDLINE: Diabetes, Gestational, Glycation End Products, Advanced, Blood Glucose, Skin. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advanced glycation end products (AGEs) can be measured non-invasively through skin autofluorescence (SAF). Studies on SAF in gestational diabetes mellitus (GDM) remain limited. This study aims to evaluate SAF in Tunisian pregnant women with GDM and its association with the requirement for insulin therapy.

Methods

A cross sectional study was conducted of 242 pregnant women who visited at the Monastir-Tunisia Center for Maternity. Screening for GDM was performed using the OGTT. 200 pregnant women were included in the study with and without GDM. We measured SAF using the AGE reader Mu device and the age-adjusted SAF-z score was calculated.

Results

Higher SAF levels and SAF-z scores were observed in pregnant women with GDM compared to healthy controls (2.1 ± 0.5 AU vs 1.9 ± 0.4 AU p < 0.001, 1.02 ± 0.9 vs 0.64 ± 0.7 p = 0.002, respectively). The ROC analysis revealed that an SAF >2.3 AU was the optimal cut-off point for predicting insulin therapy requirement with a sensitivity of 90.9% and a specificity of 69.7% ( p < 0.001).

Conclusion

SAF was increased in GDM, and can be a biomarker associated suboptimal glycemic control in pregnant women with GDM. Our findings highlight the relevance of SAF measurement and suggest SAF monitoring during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalGlycation End Products, AdvancedBlood GlucoseSkinGlycemic ControlOptical ImagingHumansFemalePregnancyCross-Sectional StudiesBiomarkersAdultPredictive Value of TestsInsulinHypoglycemic AgentsCase-Control StudiesYoung Adult

Stichwörter der Autor:innen

advanced glycation and productsgestational diabetes mellituspredictive biomarkerskin autofluorescence

Substanzen

BiomarkersGlycation End Products, AdvancedBlood GlucoseInsulinHypoglycemic Agents

Autor:innen und Institutionen

  • Laboratory of Research on Biologically Compatible Compounds, Faculty of Dental Medicine, University of Monastir, Monastir, Tunisia.
  • Department of Obstetric and Gynecology, University Hospital Fattouma Bourguiba of Monastir, Monastir, Tunisia.

ORCID-Profile: Mohsen Kerkeni

Zitieren

APA

Alakrab, M. S., Toumi, D., Selmi, A., Hajji, A., Zoukar, O., Abid, S., Faleh, R., & Kerkeni, M. (2026). Skin autofluorescence may be a biomarker associated suboptimal glycemic control in pregnant women with gestational diabetes mellitus. Diabetes & Vascular Disease Research, 23(4). https://doi.org/10.1177/14791641251398558

Vancouver

Alakrab MS, Toumi D, Selmi A, Hajji A, Zoukar O, Abid S, et al. Skin autofluorescence may be a biomarker associated suboptimal glycemic control in pregnant women with gestational diabetes mellitus. Diabetes & Vascular Disease Research. 2026;23(4). doi:10.1177/14791641251398558

BibTeX
@article{Alakrab2026,
  author = {Alakrab, Manel Salsabil and Toumi, Dhekra and Selmi, Ameni and Hajji, Ahmed and Zoukar, Olfa and Abid, Salwa and Faleh, Raja and Kerkeni, Mohsen},
  title = {Skin autofluorescence may be a biomarker associated suboptimal glycemic control in pregnant women with gestational diabetes mellitus},
  journal = {Diabetes & Vascular Disease Research},
  year = {2026},
  volume = {23},
  number = {4},
  doi = {10.1177/14791641251398558}
}
Kostenlos starten →